Based in Golden, Colorado, PharmaJet’s mission is worldwide acceptance of PharmaJet Needle-Free devices as a standard of care in the vaccine delivery market. The PharmaJet Stratis® innovative Needle-Free Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously. In August 2014, the PharmaJet Stratis® Needle-Free Injector was approved for delivery of an influenza vaccine to deliver needle-free flu shots. The PharmaJet Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016. The PharmaJet Needle-Free Injectors are easy-to-use and eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
PharmaJet Tropis Needle-free injection system
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):